[(2R)-[[3-(6-AMINO-9H-PURIN-9-YL)]-2-HYDROXY]-PROPYL]-2-O-BENZYL-ALPHA-D-XYLOPYRANOSIDE
Compound with spectra: 1 NMR
![[(2R)-[[3-(6-AMINO-9H-PURIN-9-YL)]-2-HYDROXY]-PROPYL]-2-O-BENZYL-ALPHA-D-XYLOPYRANOSIDE](/api/compound/KmiAgc9W0y5.png?ph=true&h=300&w=458 "[(2R)-[[3-(6-AMINO-9H-PURIN-9-YL)]-2-HYDROXY]-PROPYL]-2-O-BENZYL-ALPHA-D-XYLOPYRANOSIDE")
| SpectraBase Compound ID | KmiAgc9W0y5 |
|---|---|
| InChI | InChI=1S/C20H25N5O6/c21-18-15-19(23-10-22-18)25(11-24-15)6-13(26)8-30-20-17(16(28)14(27)9-31-20)29-7-12-4-2-1-3-5-12/h1-5,10-11,13-14,16-17,20,26-28H,6-9H2,(H2,21,22,23)/t13-,14-,16+,17-,20+/m0/s1 |
| InChIKey | IECRBJKHZQVDRA-WESSWTGZSA-N |
| Mol Weight | 431.45 g/mol |
| Molecular Formula | C20H25N5O6 |
| Exact Mass | 431.180484 g/mol |
| Enantiomer InChIKey | IECRBJKHZQVDRA-YDVWWWKISA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CD3OD |
1-(6-AMINO-9H-PURIN-9-YL)-2,5-ANHYDRO-1-DEOXY-L-GLUCITOL
1-(6-AMINO-9H-PURIN-9-YL)-2,5-ANHYDRO-1-DEOXY-D-GLUCITOL
(4S,5S)-5-(adenin-9-ylmethyl)-2,2-dimethyl-1,3-dioxolane-4-carbaldehyde
(4R,5S)-5-(adenin-9-ylmethyl)-2,2-dimethyl-1,3-dioxolane-4-carbonitrile
(4E,4R,5S)-5-(adenin-9-ylmethyl)-2,2-dimethyl-1,3-dioxolane-4-carbaldehyde oxime
9-[[2-(BENZYLOXYMETHYL)-3,3-DIFLUOROCYCLOPROPENYL]-METHYL]-ADENINE
4-(ADENIN-9-YL)-2,4-DIDEOXY-D-ARABINOHEXITOL
6-Amino-9-(2-hydroxy-propyl)-2-phenylpurine
2,2-DIMETHYL-PROPIONIC-ACID-3-(2-CHLORO-6-METHYLAMINO-PURIN-9-YL)-2-PHOSPHONOOXY-METHYL-PROPYLESTER
| Title | Journal or Book | Year |
|---|---|---|
| d-myo-Inositol-1,4,5-trisphosphate and Adenophostin Mimics: Importance of the Spatial Orientation of a Phosphate Group on the Biological Activity | Bioorganic & Medicinal Chemistry | 2002 |